An increase in neuroinflammatory markers such as nitric oxide, interleukin-1β (IL-1β) and tumor necrosis factor (TNF-α) has been widely reported in brains of both Alzheimer’s disease patients and transgenic AD models (reviewed in [14]). This evidence concerns the gene IL1B and Alzheimer disease.